We are developing a cutting-edge AI-Blood Diagnostic Device, which will provide state-of-the-art diagnostics and prediction of thrombosis and bleeding risks. The technology is developed based on a patented novel biomarker developed by Aimorphous which reveals day-to-day changes in the risks.